Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Reduced Disclosure Framework

2 Feb 2016 07:00

RNS Number : 7160N
Plant Health Care PLC
02 February 2016
 

 

Plant Health Care plc

2 February 2016

 

("Plant Health Care" or the "Company")

Adoption of the reduced disclosure framework within Financial Reporting Standard (FRS) 102

Following the publication of FRS 100 'Application of Financial Reporting Requirements' by the Financial Reporting Council, Plant Health Care plc is required to change its accounting framework for its entity financial statements, which currently adopt UK GAAP. It is intended for the period ended 31 December 2015 and future years that the parent entity and group subsidiaries adopt FRS 102, which is based on International Financial Reporting Standards as adopted by the European Union. As part of the adoption of FRS 102, the parent entity and group subsidiaries intend to take advantage of the "Reduced Disclosure Framework" available within FRS 102. The reduced disclosure framework is not expected to give rise to any significant changes in disclosure.

Shareholder approval to adopt FRS102 is not required, however shareholders holding 5% or more of the issued share capital of the Company may object to the use of the reduced disclosures available within FRS 102. If you have any queries regarding the Company's adoption of FRS102 or would like to object to the use of the reduced disclosure framework in the Company's financial statements, please contact Jeffrey Hovey, the Company's Chief Financial Officer at its registered office (48 Chancery Lane, London WC2A 1JF) not later than 1 March 2016.

Further information is available at: www.planthealthcare.com or please contact:

 

Plant Health Care plc

Jeff Hovey, Chief Financial OfficerTel: +19199261600 (x101)

 

Liberum

Clayton Bush / Chris Clarke

Tel: +44 (0) 20 3100 2227

 

LHA

Ed McGregor / Jody BurfeningTel: +12128383777

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBFLLBQLFBBBV
Date   Source Headline
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London
14th Nov 20187:00 amRNSPositive Developments with Harpin
8th Nov 20187:00 amRNSChange of Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSInterim Report ended 30 June 2018
12th Sep 20187:00 amRNSUS Announces Harpin aß Product Launch in Corn
20th Aug 20187:00 amRNSBlock listing Interim Review
30th Jul 20187:00 amRNSUpdate on sugarcane in Brazil
16th Jul 20187:00 amRNSTrading Statement
6th Jun 20182:39 pmRNSHolding(s) in Company
6th Jun 201811:14 amRNSResult of AGM
30th May 20187:00 amRNSGrant of Options
4th May 20185:59 pmRNSHolding(s) in Company
30th Apr 20183:11 pmRNSPublication of Annual Report and Notice of AGM
10th Apr 20187:00 amRNSResults for the year ended 31 December 2017
8th Mar 20187:00 amRNSBlock listing Interim Review
7th Mar 20183:07 pmRNSHolding(s) in Company
7th Mar 20183:06 pmRNSHolding(s) in Company
7th Mar 20183:02 pmRNSHolding(s) in Company
2nd Mar 20185:48 pmRNSHolding(s) in Company
27th Feb 20184:12 pmRNSResult of Placing and Subscription
27th Feb 20187:00 amRNSProposed Placing and Subscription
24th Jan 20187:00 amRNSTrading Statement
12th Dec 20177:00 amRNSNew Technology Update
8th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20174:40 pmRNSSecond Price Monitoring Extn
6th Dec 20174:35 pmRNSPrice Monitoring Extension
18th Sep 20177:00 amRNSHalf-year Report
21st Aug 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.